308 related articles for article (PubMed ID: 24989076)
21. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
[TBL] [Abstract][Full Text] [Related]
22. Fanconi anemia: correlating central nervous system malformations and genetic complementation groups.
Johnson-Tesch BA; Gawande RS; Zhang L; MacMillan ML; Nascene DR
Pediatr Radiol; 2017 Jun; 47(7):868-876. PubMed ID: 28283722
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis of Fanconi Anaemia by ionising radiation- or mitomycin C-induced micronuclei.
Francies FZ; Wainwright R; Poole J; De Leeneer K; Coene I; Wieme G; Poirel HA; Brichard B; Vermeulen S; Vral A; Slabbert J; Claes K; Baeyens A
DNA Repair (Amst); 2018 Jan; 61():17-24. PubMed ID: 29154021
[TBL] [Abstract][Full Text] [Related]
24. Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.
Cao AY; Huang J; Hu Z; Li WF; Ma ZL; Tang LL; Zhang B; Su FX; Zhou J; Di GH; Shen KW; Wu J; Lu JS; Luo JM; Yuan WT; Shen ZZ; Huang W; Shao ZM
Breast Cancer Res Treat; 2009 May; 115(1):51-5. PubMed ID: 18483852
[TBL] [Abstract][Full Text] [Related]
25. Aberrant Fanconi anaemia protein profiles in acute myeloid leukaemia cells.
Xie Y; de Winter JP; Waisfisz Q; Nieuwint AW; Scheper RJ; Arwert F; Hoatlin ME; Ossenkoppele GJ; Schuurhuis GJ; Joenje H
Br J Haematol; 2000 Dec; 111(4):1057-64. PubMed ID: 11167740
[TBL] [Abstract][Full Text] [Related]
26. Two common founder mutations of the fanconi anemia group G gene FANCG/XRCC9 in the Japanese population.
Yagasaki H; Oda T; Adachi D; Nakajima T; Nakahata T; Asano S; Yamashita T
Hum Mutat; 2003 May; 21(5):555. PubMed ID: 12673805
[TBL] [Abstract][Full Text] [Related]
27. Clinical and Genetic Features of Patients With Fanconi Anemia in Lebanon and Report on Novel Mutations in the FANCA and FANCG Genes.
Farah RA; Nair P; Koueik J; Yammine T; Khalifeh H; Korban R; Collet A; Khayat C; Dubois-Denghien C; Chouery E; Blanluet M; El-Hayek S; Stoppa-Lyonnet D; Megarbane A
J Pediatr Hematol Oncol; 2021 Jul; 43(5):e727-e735. PubMed ID: 32947577
[TBL] [Abstract][Full Text] [Related]
28. Fanconi anemia is associated with a defect in the BRCA2 partner PALB2.
Xia B; Dorsman JC; Ameziane N; de Vries Y; Rooimans MA; Sheng Q; Pals G; Errami A; Gluckman E; Llera J; Wang W; Livingston DM; Joenje H; de Winter JP
Nat Genet; 2007 Feb; 39(2):159-61. PubMed ID: 17200672
[TBL] [Abstract][Full Text] [Related]
29. Breast cancer and Fanconi anemia: what are the connections?
Zdzienicka MZ; Arwert F
Trends Mol Med; 2002 Oct; 8(10):458-60. PubMed ID: 12383764
[TBL] [Abstract][Full Text] [Related]
30. Molecular characterization of three novel Fanconi anemia mutations in Israeli Arabs.
Tamary H; Dgany O; Toledano H; Shalev Z; Krasnov T; Shalmon L; Schechter T; Bercovich D; Attias D; Laor R; Koren A; Yaniv I
Eur J Haematol; 2004 May; 72(5):330-5. PubMed ID: 15059067
[TBL] [Abstract][Full Text] [Related]
31. Investigation of FANCA mutations in Greek patients.
Selenti N; Sofocleous C; Kattamis A; Kolialexi A; Kitsiou S; Fryssira E; Polychronopoulou S; Kanavakis E; Mavrou A
Anticancer Res; 2013 Aug; 33(8):3369-74. PubMed ID: 23898106
[TBL] [Abstract][Full Text] [Related]
32. Analysis of the novel fanconi anemia gene SLX4/FANCP in familial breast cancer cases.
Bakker JL; van Mil SE; Crossan G; Sabbaghian N; De Leeneer K; Poppe B; Adank M; Gille H; Verheul H; Meijers-Heijboer H; de Winter JP; Claes K; Tischkowitz M; Waisfisz Q
Hum Mutat; 2013 Jan; 34(1):70-3. PubMed ID: 22911665
[TBL] [Abstract][Full Text] [Related]
33. Endocrine profiling in patients with Fanconi anemia, homozygous for a FANCG founder mutation.
Dillon B; Feben C; Segal D; du Plessis J; Reynders D; Wainwright R; Poole J; Krause A
Mol Genet Genomic Med; 2020 Aug; 8(8):e1351. PubMed ID: 32529760
[TBL] [Abstract][Full Text] [Related]
34. Profiling Fanconi Anemia Gene Mutations among Iranian Patients.
Esmail Nia G; Fadaee M; Royer R; Najmabadi H; Akbari MR
Arch Iran Med; 2016 Apr; 19(4):236-40. PubMed ID: 27041517
[TBL] [Abstract][Full Text] [Related]
35. Founder haplotype analysis of Fanconi anemia in the Korean population finds common ancestral haplotypes for a FANCG variant.
Park J; Kim M; Jang W; Chae H; Kim Y; Chung NG; Lee JW; Cho B; Jeong DC; Park IY; Park MS
Ann Hum Genet; 2015 May; 79(3):153-61. PubMed ID: 25703136
[TBL] [Abstract][Full Text] [Related]
36. Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia.
Offit K; Levran O; Mullaney B; Mah K; Nafa K; Batish SD; Diotti R; Schneider H; Deffenbaugh A; Scholl T; Proud VK; Robson M; Norton L; Ellis N; Hanenberg H; Auerbach AD
J Natl Cancer Inst; 2003 Oct; 95(20):1548-51. PubMed ID: 14559878
[TBL] [Abstract][Full Text] [Related]
37. Screening for large genomic rearrangements in the FANCA gene reveals extensive deletion in a Finnish breast cancer family.
Solyom S; Winqvist R; Nikkilä J; Rapakko K; Hirvikoski P; Kokkonen H; Pylkäs K
Cancer Lett; 2011 Mar; 302(2):113-8. PubMed ID: 21236561
[TBL] [Abstract][Full Text] [Related]
38. The Fanconi anemia DNA damage repair pathway in the spotlight for germline predisposition to colorectal cancer.
Esteban-Jurado C; Franch-Expósito S; Muñoz J; Ocaña T; Carballal S; López-Cerón M; Cuatrecasas M; Vila-Casadesús M; Lozano JJ; Serra E; Beltran S; Brea-Fernández A; Ruiz-Ponte C; Castells A; Bujanda L; Garre P; Caldés T; Cubiella J; Balaguer F; Castellví-Bel S
Eur J Hum Genet; 2016 Oct; 24(10):1501-5. PubMed ID: 27165003
[TBL] [Abstract][Full Text] [Related]
39. Cellular characterization of cells from the Fanconi anemia complementation group, FA-D1/BRCA2.
Godthelp BC; van Buul PP; Jaspers NG; Elghalbzouri-Maghrani E; van Duijn-Goedhart A; Arwert F; Joenje H; Zdzienicka MZ
Mutat Res; 2006 Oct; 601(1-2):191-201. PubMed ID: 16920162
[TBL] [Abstract][Full Text] [Related]
40. Further evidence for the contribution of the RAD51C gene in hereditary breast and ovarian cancer susceptibility.
Vuorela M; Pylkäs K; Hartikainen JM; Sundfeldt K; Lindblom A; von Wachenfeldt Wäppling A; Haanpää M; Puistola U; Rosengren A; Anttila M; Kosma VM; Mannermaa A; Winqvist R
Breast Cancer Res Treat; 2011 Dec; 130(3):1003-10. PubMed ID: 21750962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
